Comparison of early vascular morphological changes between bioresorbable poly-L-lactic acid scaffolds and metallic stents in porcine iliac arteries

REFERENCES

• Onuma Y, Ormiston J, Serruys PW. Bioresorbable Scaffold Technologies. Circ J 2011; 75:509-20; PMID:21301138; http://dx.doi.org/10.1253/circj.CJ-10-1135
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. New Engl J Med 2002; 346:1773-80; PMID:12050336; http://dx.doi.org/10.1056/NEJMoa012843
   PubMed Web of Science ®Google Scholar
• Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, Group SS. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. New Engl J Med 2007; 356:1009-19; PMID:17296822; http://dx.doi.org/10.1056/NEJMoa067722
   PubMed Web of Science ®Google Scholar
• Brugaletta S, Gogas BD, Garcia-Garcia HM, Farooq V, Girasis C, Heo JH, van Geuns RJ, de Bruyne B, Dudek D, Koolen J, et al. Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments. Circ J 2012; 76:1616-23; PMID:22531596; http://dx.doi.org/10.1253/circj.CJ-11-1416
   PubMed Web of Science ®Google Scholar
• Uurto I, Juuti H, Parkkinen J, Kellomaki M, Keski-Nisula L, Nevalainen T, Tormala P, Salenius JP. Biodegradable self-expanding poly-L/D-lactic acid vascular stent: a pilot study in canine and porcine iliac arteries. J Endovasc Ther 2004; 11:712-8; PMID:15615562; http://dx.doi.org/10.1583/04-127MR.1
   PubMed Web of Science ®Google Scholar
• Werner M, Micari A, Cioppa A, Vadala G, Schmidt A, Sievert H, Rubino P, Angelini A, Scheinert D, Biamino G. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study. JACC Cardiovasc Interv 2014; 7:305-12; PMID:24529932; http://dx.doi.org/10.1177/1526602815620618
   PubMed Web of Science ®Google Scholar
• Durand E, Sharkawi T, Leclerc G, Raveleau M, van der Leest M, Vert M, Lafont A. Head-to-head comparison of a drug-free early programmed dismantling polylactic acid bioresorbable scaffold and a metallic stent in the porcine coronary artery: six-month angiography and optical coherence tomographic follow-up study. Circ Cardiovasc Interv 2014; 7:70-9; PMID:24368820; http://dx.doi.org/10.1161/CIRCINTERVENTIONS.113.000738
   PubMed Web of Science ®Google Scholar
• Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H. Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans. Circulation 2000; 102:399-404.
   PubMed Web of Science ®Google Scholar
• Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T, Takeuchi E, Inuzuka Y, Takeda S, Hata T, et al. Long-term (>10 years) clinical outcomes of first-in-human biodegradable poly-l-lactic acid coronary stents: Igaki-Tamai stents. Circulation 2012; 125:2343-2353; PMID:22508795; http://dx.doi.org/10.1161/CIRCULATIONAHA.110.000901
   PubMed Web of Science ®Google Scholar
• Bunger CM, Grabow N, Sternberg K, Goosmann M, Schmitz KP, Kreutzer HJ, Ince H, Kische S, Nienaber CA, Martin DP, et al. A biodegradable stent based on poly(L-lactide) and poly(4-hydroxybutyrate) for peripheral vascular application: preliminary experience in the pig. J Endovasc Ther 2007; 14:725-733; PMID:17924740; http://dx.doi.org/10.1583/1545-1550(2007)14[725:ABSBOP]2.0.CO;2
   PubMed Web of Science ®Google Scholar
• Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19:267-274; PMID:1732351
   PubMed Web of Science ®Google Scholar
• Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31:224-230; PMID:9426044
   PubMed Web of Science ®Google Scholar
• Curcio A, Torella D, Indolfi C. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting. Circ J 2011; 75:1287-1296; PMID:21532177; http://dx.doi.org/10.1253/circj.CJ-11-0366
   PubMed Web of Science ®Google Scholar
• Bunger CM, Grabow N. Iliac anastomotic stenting with a sirolimus-eluting biodegradable poly-L-lactide stent: a preliminary study after 6 weeks. J Endovasc Ther 2006; 13:630-9; PMID:17042669; http://dx.doi.org/10.1583/06-1899R.1
   PubMed Web of Science ®Google Scholar
• Uurto I, Mikkonen J, Parkkinen J, Keski-Nisula L, Nevalainen T, Kellomaki M, Tormala P, Salenius JP. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study. J Endovasc Ther 2005; 12:371-379; PMID:15943514; http://dx.doi.org/10.1583/05-1525.1
   PubMed Web of Science ®Google Scholar
• Yamawaki T, Shimokawa H, Kozai T, Miyata K, Higo T, Tanaka E, Egashira K, Shiraishi T, Tamai H, Igaki K, et al. Intramural delivery of a specific tyrosine kinase inhibitor with biodegradable stent suppresses the restenotic changes of the coronary artery in pigs in vivo. J Am Coll Cardiol 1998; 32:780-786; PMID:9741527
   PubMed Web of Science ®Google Scholar
• Uurto I, Hamalainen M, Suominen V, Laurila M, Kotsar A, Isotalo T, Tammela TL, Kellomaki M, Salenius JP. Muraglitazar-eluting bioabsorbable vascular stent inhibits neointimal hyperplasia in porcine iliac arteries. J Vasc Interv Radiol 2015; 26:124-130; PMID:25454655; http://dx.doi.org/10.1016/j.jvir.2014.10.005
   PubMed Web of Science ®Google Scholar
• Werner M, Schmidt A, Scheinert S, Banning-Eichenseer U, Ulrich M, Bausback Y, Steiner S, Scheinert D. Evaluation of the biodegradable Igaki-Tamai scaffold after drug eluting balloon treatment of de novo superficial femoral artery lesions: the GAIA-DEB study. J Endovasc Ther 2016; 23:92-7; PMID:26620399; http://dx.doi.org/10.1177/1526602815620618
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Farb A, Lafont M. Drug eluting stents: are human and animal studies comparable? Heart 2003; 89:133-138; PMID:12527658
   PubMed Web of Science ®Google Scholar